Shareholder Alert: Ademi LLP investigates whether Albireo Pharma, Inc. has obtained a Fair Price in its transaction with Ipsen

Provided By PR Newswire

Last update: Jan 9, 2023

MILWAUKEE, Jan. 9, 2023 /PRNewswire/ -- Ademi LLP is investigating Albireo (Nasdaq: ALBO) for possible breaches of fiduciary duty and other violations of law in its transaction with Ipsen.